The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Hamas in a 'positive spirit' ahead of Cairo truce talks
Students erect pro-Palestinian camp at Ireland's Trinity College
Russian suspected cybercrime kingpin pleads guilty in US: TASS
Indonesia plans to use corn, sugarcane, seaweed for making bioethanol
China launches mission to return samples from Moon's far side
Fresh chaos, arrests on US college campuses as police flatten camp at UCLA
Indonesia to permanently relocate 10,000 people after Ruang volcano eruptions
Strong quake strikes Philippines, aftershocks expected
